Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
September 7, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for June 3, 2005 Subscribe to this News Feed      
 

Parker & Waichman, LLP Contacted by Viagra, Cialis & Levitra Users Claiming Vision Problems, Blindness & Other Side Effects; Firm to File Lawsuits in Coming Weeks

Drug side effects lawyer receiving hundrends of inquiries from Viagra, Cialis and Levitra users that claim to have impaired vision or complete vision loss (blindness) after using these drugs. The FDA is evaluating erectilie dysfunction drugs link to NAION.

New York, NY (PRWEB) June 3, 2005 -- For the past 6 months, Parker & Waichman, LLP (www.yourlawyer.com) has been contacted by prospective clients who claim to have suffered loss of vision as a result of using the erectile dysfunction drug Viagra (sildenafil citrate). Last week, the FDA announced that it is investigating a link between erectile dysfunction drugs and NAION - nonarteritic anterior ischemic optic neuropathy - which can cause blindness. Parker & Waichman, LLP has also received a significant number of inquiries from Cialis and Levitra users who claim to have suffered vision loss after using those drugs. Viagra, Cialis and Levitra patients can learn more by visiting http://www.yourlawyer.com/practice/overview.htm?topic=Viagra.

In its announcement last week, The Food and Drug Administration said it had received 43 reports of varying degrees of vision loss, including blindness, among users of erectile dysfunction drugs. There were 38 reports of blindness among Viagra users (Six patients had vision loss within 24 hours after use of Viagra), four among Cialis users and one among Levitra users. Eli Lilly & Co. (NYSE: LLY) and ICOS Corp. (NASDAQ: ICOS), the makers of Cialis, have already added a warning about possible vision loss to the drugs label. The FDA has said it is in discussions with Pfizer Inc. (NYSE: PFE) the maker of Viagra, and the makers of Levitra, Bayer AG (NYSE: BAY), GlaxoSmithKline PLC (NYSE: GSK) and Schering Plough CP (NYSE: SGP) about warnings on those drugs labels. Over 30 million men worldwide have used an erectile dysfunction drug since Viagra came onto the market in 1998.

NAION occurs when blood flow to the optic nerve is blocked. NAION can be temporary, but it is usually permanent and often leads to legal blindness. Parker & Waichman, LLP continues to offer free case consultations to Viagra, Levitra and Cialis users and their families. Patients can click the appropriate link below for a free consultation: Viagra Patient Case Consultation: http://www.yourlawyer.com/practice/overview.htm?topic=Viagra

Cialis Patient Case Consultation:
http://www.yourlawyer.com/practice/overview.htm?topic=Cialis

Levitra Patient Case Consultation: http://www.yourlawyer.com/practice/overview.htm?topic=Levitra

For more information on Parker & Waichman, LLP please visit: (http://www.yourlawyer.com) or call 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker & Waichman, LLP
David Krangle, Esq.
(800) LAW-INFO (800-529-4636) (toll free)
dkrangle@yourlawyer.com
http://www.yourlawyer.com

# # #

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
David Krangle
PARKER & WAICHMAN, LLP
516-466-6500
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright